Enhanced Games Organizer to Reveal Details – La Presse
- The organization behind the Enhanced games, a proposed sporting event allowing performance-enhancing drugs, is preparing to become a publicly traded company.
- D'Souza intends to list the company on the New York stock Exchange (NYSE) under the ticker symbol "GAME," aiming to raise capital to fund the inaugural Enhanced Games,...
- The enhanced Games concept, first publicly discussed in 2023, proposes a multi-sport event where athletes are explicitly permitted to use performance-enhancing drugs, including gene editing and pharmaceuticals. ...
Enhanced Games Organizer to Launch Public Company
Table of Contents
A new Era for the Controversial Competition
The organization behind the Enhanced games, a proposed sporting event allowing performance-enhancing drugs, is preparing to become a publicly traded company. This move signals a critically important step towards realizing the ambitious, and highly debated, vision of its founder, Aron D’Souza.
D’Souza intends to list the company on the New York stock Exchange (NYSE) under the ticker symbol “GAME,” aiming to raise capital to fund the inaugural Enhanced Games, currently scheduled for December 2025.The initial public offering (IPO) is expected to value the company at approximately $200 million,according to filings.
What are the Enhanced Games?
The enhanced Games concept, first publicly discussed in 2023, proposes a multi-sport event where athletes are explicitly permitted to use performance-enhancing drugs, including gene editing and pharmaceuticals. D’Souza argues this approach represents the “future of sports,” acknowledging the widespread, yet often hidden, use of such substances in elite athletics. He positions the Games as a transparent choice to traditional sporting regulations.
The planned events include track and field, swimming, weightlifting, and combat sports. The organizers claim the Games will attract athletes who are currently penalized or forced to compete clandestinely due to anti-doping rules.However, the concept has drawn substantial criticism from anti-doping advocates and medical professionals who raise concerns about athlete safety and the ethical implications of openly promoting performance enhancement.
Financial Details and Future Plans
The company’s prospectus details plans to use the IPO proceeds for venue construction,athlete recruitment,marketing,and operational expenses. A significant portion of the funding will be allocated to developing and implementing safety protocols, though the specifics of these protocols remain a point of contention. The company anticipates generating revenue through ticket sales, broadcasting rights, sponsorships, and possibly, pharmaceutical partnerships.
The Enhanced Games’ business model relies heavily on attracting a substantial audience interested in witnessing the limits of human athletic potential, unconstrained by current doping regulations. the success of the IPO and the Games themselves will depend on overcoming significant public skepticism and navigating complex legal and ethical challenges.